KORNITZER CAPITAL MANAGEMENT INC /KS – Halozyme Therapeutics, Inc. Transaction History
KORNITZER CAPITAL MANAGEMENT INC /KS portfolio value:
$17.71M
portfolio value
KORNITZER CAPITAL MANAGEMENT INC /KS quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.02% | -100 shares | -2.00M | $39.54 | 447.91K |
| Q2 2022 | share | Decrease | -18.05% | -98.70K shares | -2.09M | $44 | 448.01K |
| Q1 2022 | share | 0.00% | 0 shares | -180K | $39.88 | 546.71K | |
| Q4 2021 | share | Increase | +17.59% | 81.78K shares | 3.07M | $40.32 | 546.71K |
| Q3 2021 | share | 0.00% | 0 shares | -2.19M | $40.68 | 464.93K | |
| Q2 2021 | share | Increase | +12.93% | 53.23K shares | 3.94M | $45.41 | 464.93K |
| Q1 2021 | share | 0.00% | 0 shares | -419K | $41.69 | 411.69K | |
| Q4 2020 | share | Decrease | -10.95% | -50.60K shares | 5.43M | $42.71 | 411.69K |
| Q3 2020 | share | Decrease | -1.06% | -4.96K shares | -378K | $26.28 | 462.3K |
| Q2 2020 | share | Decrease | -0.74% | -3.48K shares | 4.05M | $26.81 | 467.26K |
| Q1 2020 | share | Increase | +76.38% | 203.85K shares | 3.73M | $17.99 | 470.75K |
| Q4 2019 | share | Increase | 0.00% | 266.89K shares | 4.73M | $17.73 | 266.89K |